亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南豐達化工化學有限公司  

胺類,醇類,醚類,苯類,烯烴類

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:賈俊青
  • 電話:0531-82687654
  • 傳真:0531-88691900
  • QQ:1563519054
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 阿侖膦酸鈉
阿侖膦酸鈉
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
庫存 100公斤起訂1公斤
品牌 匯豐達
型號 121268-17-5
規格 99
過期 長期有效
更新 2012-01-06 09:01
 
詳細信息
分子式:C4H12NO7P2Na·3H2O
分子量:325.12
CAS No.:121268-17-5
結構式:
·性狀:白色晶體粉末
標準:
·外觀:                                 白色晶體粉末
·純度(%,以干品計):         98--102
·pH                            4.0 - 5.0
 ·干燥失重(%)                   16.0—17.0
·亞磷酸鹽(wt%):              ≤0.1
·重金屬含量(ppm):          ≤10
 包裝、運輸、貯存
  包裝:25公斤凈重,紙板桶包裝。另可根據客戶要求定制包裝
  運輸:防火、防潮
   貯存:防火、防潮、通風、干燥。
用途
用于生產新型抗骨質疏松藥——阿侖瞵酸鈉的成品藥。

©2025 濟南豐達化工化學有限公司 版權所有   技術支持:化工網   訪問量:9167  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |